Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mahshid AkhavanRahnama"'
Autor:
Azam Habibi, Masoud Soleimani, Amir Atashi, Mahshid AkhavanRahnama, Azadeh Anbarlou, Mansoureh Ajami, Monireh Ajami
Publikováno v:
Avicenna Journal of Phytomedicine, Vol 8, Iss 4, Pp 350-357 (2018)
Objective: The application of human cord blood (hCB) is limited to children by using relatively small volume of cord blood that does not contain enough hematopoietic stem cells (HSCs). So, efforts for applying cord blood stem cells in transplantation
Externí odkaz:
https://doaj.org/article/8a119df1c86e46fdaa327fd8501deef5
Autor:
Azadeh Anbarlou, Majid Mossahebi-Mohammadi, S Kaviani, Mahshid AkhavanRahnama, Amir Atashi, Kaveh Tari
Publikováno v:
Biologicals. 45:15-19
Hepatocyte Growth Factor (HGF) plays a pivotal role in hematopoiesis, motility, growth and mobilization of hematopoietic stem/progenitor cells (HSPCs). HGF mainly is produced by bone marrow mesenchymal stem cells (BM-MSCs). MSCs express erythropoieti
Publikováno v:
Majallah-i ̒Ilmī-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Simnān, Vol 19, Iss 1, Pp 175-182 (2017)
Introduction: Hematopoetic stem cell transplantation (HSCT) is one of the treatment approaches for malignant and non-malignant hematologic diseases. The most important disadvantage of UCB in HSCT is low number of cells that can be collected. So, diff
Autor:
Ehsan Arefian, Masoud Soleimani, Azadeh Anbarlou, Amir Atashi, Mahshid AkhavanRahnama, Giorgio Gallinella
Human Parvovirus B19 (PVB19) is one of the most important pathogens that targets erythroid lineage. Many factors were mentioned for restriction to erythroid progenitor cells (EPCs). Previous studies showed that in non-permissive cells VP1 and VP2 (st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c7e77f9346736222364c491e939db8
http://hdl.handle.net/11585/542003
http://hdl.handle.net/11585/542003
Autor:
Majid Mossahebi-Mohammadi, Masoud Soleimani, Amir Atashi, Mahbobeh Bohloli, Azadeh Anbarlou, Mahshid AkhavanRahnama
Publikováno v:
In vitro cellulardevelopmental biology. Animal. 51(6)
T cell acute lymphoblastic leukemia (T-ALL) is a hematological disease including malignancy of T cell precursors. There are some T-ALL patients that are drug-resistant. A major cause of treatment failure in cancers can be associated with the existenc